-
Cramer: Retailers Just Proved They're Far From Dead
Friday, November 17, 2017 - 2:07pm | 419Retailers are making a strong statement in their earnings report that they are far from dead, so says CNBC's Jim Cramer. Many of the companies who reported their earnings in the past few days made it clear they're putting up strong defenses against Amazon.com, Inc. (NASDAQ: AMZN), Cramer...
-
Jim Cramer Talks Msci's Rumor-Induced Surge
Wednesday, March 15, 2017 - 10:49am | 424Shares of Msci Inc (NYSE: MSCI) soared higher by 11 percent Wednesday morning following an unconfirmed report the company is a takeover target. Msci compiles some of the most notable market indices and was reportedly offered $120 per share to be acquired by S&P Global Inc (NYSE: SPGI), the...
-
Cramer On Gamestop: The Old Narrative No Longer Applies
Wednesday, November 2, 2016 - 1:01pm | 260GameStop Corp. (NYSE: GME)'s stock plunged more than 10 percent and hit a new 52-week low of $20.10 after the company reported preliminary results for its third quarter and revised earnings per share guidance for the full fiscal year. Jim Cramer offered his take on GameStop's decline...
-
Jim Cramer On Hasbro's Earnings: Will Anyone Care About 'Great' Quarter?
Monday, October 17, 2016 - 11:08am | 265Jim Cramer discussed Hasbro, Inc. (NASDAQ: HAS)'s quarterly results during Monday's "Mad Dash" segment. Cramer was quick to point out that Hasbro's report marks a "great" quarter after reporting a disappointing second quarter back in July. At that time, the...
-
Cramer Talks About Ulta Salon's 'Beautiful' Run
Thursday, October 13, 2016 - 12:23pm | 286Shares of Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) were trading higher by more than 9 percent Thursday after the company revised its third quarter and full year guidance. According to Jim Cramer, Ulta is one of the few "selfie generation" stocks. He noted that the...
-
Jim Cramer: Tesla May Not Be Forward Looking Enough
Thursday, October 6, 2016 - 11:00am | 295Shares of Tesla Motors Inc (NASDAQ: TSLA) were trading lower by more than 3 percent after Goldman Sachs downgraded the stock to from Buy to Neutral with a price target slashed from $240 to $185. Jim Cramer offered his take on the downgrade on Thursday. Related Link: Goldman Sachs Downgrades...
-
Jim Cramer Praises Constellation Brands
Wednesday, October 5, 2016 - 10:57am | 301Shares of Constellation Brands, Inc. (NYSE: STZ) hit a new 52-week high of $173.55 Wednesday after the company reported its second quarter results and boosted its guidance. The company's strong earnings print attracted the attention of Jim Cramer, who made the producer and marketer of...
-
Cramer: Macy's Guided Down 'Too Far'
Thursday, August 11, 2016 - 12:20pm | 262Macy's Inc (NYSE: M) may have surprised some investors Thursday when it reported a better-than-expected Q2 print, which serves as an indication the struggling retailer is in the midst of a turnaround. Jim Cramer has a somewhat different take on Macy's stock. During his daily "Mad...
-
Cramer On Lululemon's Director Resignation: 'Her Qualifications Weren't As Strong' And Served As A 'Life Coach'
Tuesday, August 9, 2016 - 11:22am | 292Lululemon Athletica inc. (NASDAQ: LULU) said in a form 8-K filing dated August 3 that its longest-standing member of its Board of Directors, Rhoda Pitcher, resigned from her position to "pursue other opportunities." Lululemon added in its filing the resignation is "not due to any...
-
Jim Cramer Says Joy Global's Buyout Is A 'Remarkable Deal'
Thursday, July 21, 2016 - 12:18pm | 371Joy Global Inc. (NYSE: JOY) announced Thursday morning it has agreed to sell itself to Komatsu America Corp, a subsidiary of Japan-based Komatsu Ltd (ADR) (OTC: KMTUY), for $3.7 billion, or $28.30 per share. The price tag on the deal implies a 48 percent premium to the volume weighted average...
-
The FDA Showing Valeant Some Love With Recent Drug Approvals
Wednesday, July 20, 2016 - 1:58pm | 292Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s stock got a boost on Wednesday after the U.S. Food and Drug Administration (FDA) approved the company's RELISTOR Tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain. Valeant said in a press release that it...
-
Jim Cramer Says Thermo Fisher's CEO 'Does Not Fool Around' And Is 'One Of The Greats'
Friday, May 27, 2016 - 11:42am | 267Thermo Fisher Scientific Inc. (NYSE: TMO) announced on Friday it has agreed to acquire FEI Company (NASDAQ: FEIC) in a deal that values the scientific instruments company at $4.2 billion. The transaction was also the focus of CNBC's daily "The Mad Dash" segment. Cramer noted...
-
Jim Cramer: Investors Haven't Focused On Dycom, 'You Need Companies Like Dycom'
Wednesday, May 25, 2016 - 11:55am | 242Dycom Industries, Inc. (NYSE: DY) is a provider of engineering, construction, maintenance and installation services to telecommunications providers. The company's shares surged higher by more than 12 percent on Wednesday after the company reported a better-than-expected third-quarter print. The...
-
Cramer Says Applied Materials' Call Was One Of The 'Most Bullish' Events In Years
Friday, May 20, 2016 - 10:39am | 252Shares of Applied Materials, Inc. (NASDAQ: AMAT) were trading higher by more than 13 percent Friday morning following the company's top-and-bottom second quarter earnings beat and a strong outlook for the coming quarter. Jim Cramer praised the stock during his daily "The Mad Dash...
-
Jim Cramer Talks Delta Air Lines, Off-Price Retailers
Monday, May 16, 2016 - 10:44am | 358Delta Air Lines, Inc. (NYSE: DAL) said in an investor presentation on Monday that it plans on reducing its capacity plan for the bottom half of 2016. Specifically, the company plans on removing around 1 point of planned capacity growth for the fourth quarter and for overall capacity growth to...